Status:
COMPLETED
Pediatric Ease of Use ELLIPTA Items
Lead Sponsor:
GlaxoSmithKline
Collaborating Sponsors:
RTI Health Solutions(RTI HS)
Conditions:
Asthma
Eligibility:
All Genders
5+ years
Brief Summary
A range of devices has been developed to administer inhaled therapy for asthma, including dry powder inhaler (DPI) devices. ELLIPTA is a DPI that is preloaded with a drug therapy to treat asthmatic su...
Eligibility Criteria
Inclusion
- Child inclusion criteria
- Be 5 to 11 years of age
- Have asthma
- Currently use a maintenance inhaler to treat their asthma
- Be willing and able to provide assent
- Be willing and able to participate in a 45-minute interview in English Caregiver inclusion criteria
- Above 18+ years of age
- Be a caregiver (parent or legal guardian) of a pediatric subject with asthma that meets the criteria above
- Be willing and able to provide signed and dated informed consent and parental permission in English
- Be willing and able to participate in a 45-minute interview
Exclusion
- Nil
Key Trial Info
Start Date :
October 17 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2017
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT03315572
Start Date
October 17 2017
End Date
December 1 2017
Last Update
January 28 2019
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
GSK Investigational Site
Southfield, Michigan, United States, 48034
2
GSK Investigational Site
Raleigh, North Carolina, United States, 27612